{"pmid":32489797,"pmcid":"PMC7218760","title":"The Heart in the Time of the 'Coronavirus'.","text":["The Heart in the Time of the 'Coronavirus'.","Glob Heart","Perel, Pablo","Grobbee, Diederick E","32489797"],"journal":"Glob Heart","authors":["Perel, Pablo","Grobbee, Diederick E"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489797","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.5334/gh.786","keywords":["cardiology","coronavirus"],"weight":0,"_version_":1668623433643065345,"score":9.490897,"similar":[{"pmid":32405088,"pmcid":"PMC7219407","title":"Cardiological society of India position statement on COVID-19 and heart failure.","text":["Cardiological society of India position statement on COVID-19 and heart failure.","The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority.","Indian Heart J","Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K","32405088"],"abstract":["The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority."],"journal":"Indian Heart J","authors":["Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405088","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ihj.2020.04.012","keywords":["covid-19","csi","heart failure","cardiology","corona"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666802845342498817,"score":48.493076}]}